| Name | Title | Contact Details |
|---|---|---|
Robert Parker |
Chief Clinical Officer, Chief Compliance Officer | Profile |
Erik Pahl |
General Counsel | Profile |
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.
Meadowmere Assisted Living is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.
Informatics Corporation of America is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Taylor & Associates is a Winterville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.